Cessation of antibiotics regardless of ANC is safe in children with febrile neutropenia: A preliminary prospective trial

J. Kennenth, Karen Leamer, Lorrie Odom, Brian Greffe, Linda Stork

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Purpose: This study was designed to evaluate the safety and efficacy of stopping antibiotic treatment regardless of absolute neutrophil count (ANC) or signs of impending neutrophil recovery in children with febrile neutropenia (FN) and no identifiable infectious source. Patients and Methods: Thirty-two consecutive cases of FN without identifiable source were prospectively evaluated. Patients were examined, cultured, and initially treated with ceftazidime ± vancomycin. Antibiotics were discontinued and patients discharged regardless of ANC (WBC/μl X [% segs + bands]) once all the following criteria were met: Afebrile × 24 h; cultures negative at 48 h; thermometer and telephone available at home. Prompt notification of fever (T > 38.3°C) and readmission were required. Results: Median ANC was 60/μl on admission and 160/μl at discharge. Median length of treatment was 3 days. Four patients were readmitted for FN, and two patients were readmitted afebrile for cultures which became positive after discharge. None of the 32 cases suffered apparent complications from early discharge. Conclusion: Results of this preliminary trial suggest that cessation of antibiotics regardless of ANC is safe in cases of FN without identifiable source, provided that marrow is not infiltrated and that recurrent fever receives prompt antibiotic retreatment.

Original languageEnglish (US)
Pages (from-to)325-330
Number of pages6
JournalJournal of Pediatric Hematology/Oncology
Volume17
Issue number4
StatePublished - 1995
Externally publishedYes

Fingerprint

Febrile Neutropenia
Neutrophils
Anti-Bacterial Agents
Fever
Thermometers
Retreatment
Ceftazidime
Vancomycin
Telephone
Bone Marrow
Safety
Therapeutics

Keywords

  • Antibiotics
  • Fever
  • Hospitalization
  • Infections
  • Malignancy
  • Neoplasms
  • Neutropenia
  • Pediatrics

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Pediatrics, Perinatology, and Child Health

Cite this

Cessation of antibiotics regardless of ANC is safe in children with febrile neutropenia : A preliminary prospective trial. / Kennenth, J.; Leamer, Karen; Odom, Lorrie; Greffe, Brian; Stork, Linda.

In: Journal of Pediatric Hematology/Oncology, Vol. 17, No. 4, 1995, p. 325-330.

Research output: Contribution to journalArticle

@article{03ccf70a29ce4a1aac57e2bee944a524,
title = "Cessation of antibiotics regardless of ANC is safe in children with febrile neutropenia: A preliminary prospective trial",
abstract = "Purpose: This study was designed to evaluate the safety and efficacy of stopping antibiotic treatment regardless of absolute neutrophil count (ANC) or signs of impending neutrophil recovery in children with febrile neutropenia (FN) and no identifiable infectious source. Patients and Methods: Thirty-two consecutive cases of FN without identifiable source were prospectively evaluated. Patients were examined, cultured, and initially treated with ceftazidime ± vancomycin. Antibiotics were discontinued and patients discharged regardless of ANC (WBC/μl X [{\%} segs + bands]) once all the following criteria were met: Afebrile × 24 h; cultures negative at 48 h; thermometer and telephone available at home. Prompt notification of fever (T > 38.3°C) and readmission were required. Results: Median ANC was 60/μl on admission and 160/μl at discharge. Median length of treatment was 3 days. Four patients were readmitted for FN, and two patients were readmitted afebrile for cultures which became positive after discharge. None of the 32 cases suffered apparent complications from early discharge. Conclusion: Results of this preliminary trial suggest that cessation of antibiotics regardless of ANC is safe in cases of FN without identifiable source, provided that marrow is not infiltrated and that recurrent fever receives prompt antibiotic retreatment.",
keywords = "Antibiotics, Fever, Hospitalization, Infections, Malignancy, Neoplasms, Neutropenia, Pediatrics",
author = "J. Kennenth and Karen Leamer and Lorrie Odom and Brian Greffe and Linda Stork",
year = "1995",
language = "English (US)",
volume = "17",
pages = "325--330",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Cessation of antibiotics regardless of ANC is safe in children with febrile neutropenia

T2 - A preliminary prospective trial

AU - Kennenth, J.

AU - Leamer, Karen

AU - Odom, Lorrie

AU - Greffe, Brian

AU - Stork, Linda

PY - 1995

Y1 - 1995

N2 - Purpose: This study was designed to evaluate the safety and efficacy of stopping antibiotic treatment regardless of absolute neutrophil count (ANC) or signs of impending neutrophil recovery in children with febrile neutropenia (FN) and no identifiable infectious source. Patients and Methods: Thirty-two consecutive cases of FN without identifiable source were prospectively evaluated. Patients were examined, cultured, and initially treated with ceftazidime ± vancomycin. Antibiotics were discontinued and patients discharged regardless of ANC (WBC/μl X [% segs + bands]) once all the following criteria were met: Afebrile × 24 h; cultures negative at 48 h; thermometer and telephone available at home. Prompt notification of fever (T > 38.3°C) and readmission were required. Results: Median ANC was 60/μl on admission and 160/μl at discharge. Median length of treatment was 3 days. Four patients were readmitted for FN, and two patients were readmitted afebrile for cultures which became positive after discharge. None of the 32 cases suffered apparent complications from early discharge. Conclusion: Results of this preliminary trial suggest that cessation of antibiotics regardless of ANC is safe in cases of FN without identifiable source, provided that marrow is not infiltrated and that recurrent fever receives prompt antibiotic retreatment.

AB - Purpose: This study was designed to evaluate the safety and efficacy of stopping antibiotic treatment regardless of absolute neutrophil count (ANC) or signs of impending neutrophil recovery in children with febrile neutropenia (FN) and no identifiable infectious source. Patients and Methods: Thirty-two consecutive cases of FN without identifiable source were prospectively evaluated. Patients were examined, cultured, and initially treated with ceftazidime ± vancomycin. Antibiotics were discontinued and patients discharged regardless of ANC (WBC/μl X [% segs + bands]) once all the following criteria were met: Afebrile × 24 h; cultures negative at 48 h; thermometer and telephone available at home. Prompt notification of fever (T > 38.3°C) and readmission were required. Results: Median ANC was 60/μl on admission and 160/μl at discharge. Median length of treatment was 3 days. Four patients were readmitted for FN, and two patients were readmitted afebrile for cultures which became positive after discharge. None of the 32 cases suffered apparent complications from early discharge. Conclusion: Results of this preliminary trial suggest that cessation of antibiotics regardless of ANC is safe in cases of FN without identifiable source, provided that marrow is not infiltrated and that recurrent fever receives prompt antibiotic retreatment.

KW - Antibiotics

KW - Fever

KW - Hospitalization

KW - Infections

KW - Malignancy

KW - Neoplasms

KW - Neutropenia

KW - Pediatrics

UR - http://www.scopus.com/inward/record.url?scp=0028871799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028871799&partnerID=8YFLogxK

M3 - Article

C2 - 7583388

AN - SCOPUS:0028871799

VL - 17

SP - 325

EP - 330

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 4

ER -